These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37752527)

  • 21. Smoking identified as preferred mode of opioid safe supply use; investigating correlates of smoking preference through a 2021 cross-sectional study in British Columbia.
    Kamal A; Ferguson M; Xavier JC; Liu L; Graham B; Lock K; Buxton JA
    Subst Abuse Treat Prev Policy; 2023 May; 18(1):27. PubMed ID: 37194018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bridging the Gap in Harm Reduction Using Mobile Overdose Response Services (MORS) in the Context of the COVID-19 Pandemic: A Qualitative Study.
    Seo B; Rioux W; Rider N; Teare A; Jones S; Taplay P; Ghosh SM
    J Urban Health; 2024 Apr; 101(2):252-261. PubMed ID: 38514599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities.
    Korthuis PT; Cook RR; Foot CA; Leichtling G; Tsui JI; Stopka TJ; Leahy J; Jenkins WD; Baker R; Chan B; Crane HM; Cooper HL; Feinberg J; Zule WA; Go VF; Estadt AT; Nance RM; Smith GS; Westergaard RP; Van Ham B; Brown R; Young AM
    JAMA Netw Open; 2022 Aug; 5(8):e2226544. PubMed ID: 35969400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings.
    MacKinnon L; Socías ME; Bardwell G
    J Subst Abuse Treat; 2020 Dec; 119():108153. PubMed ID: 33032862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Housing and overdose: an opportunity for the scale-up of overdose prevention interventions?
    Bardwell G; Collins AB; McNeil R; Boyd J
    Harm Reduct J; 2017 Dec; 14(1):77. PubMed ID: 29212507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
    Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: A retrospective case-control study.
    Smolina K; Crabtree A; Chong M; Park M; Mill C; Zhao B; Schütz CG
    Subst Abus; 2022; 43(1):92-98. PubMed ID: 32441588
    [No Abstract]   [Full Text] [Related]  

  • 29. Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada.
    Notta D; Black B; Chu T; Joe R; Lysyshyn M
    Drug Alcohol Depend; 2019 Mar; 196():46-50. PubMed ID: 30665151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with obtaining prescribed safer supply among people accessing harm reduction services: findings from a cross-sectional survey.
    Palis H; Haywood B; McDougall J; Xavier CG; Desai R; Tobias S; Burgess H; Ferguson M; Liu L; Kinniburgh B; Slaunwhite AK; Crabtree A; Buxton JA
    Harm Reduct J; 2024 Jan; 21(1):5. PubMed ID: 38184576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.
    Papamihali K; Yoon M; Graham B; Karamouzian M; Slaunwhite AK; Tsang V; Young S; Buxton JA
    Harm Reduct J; 2020 Nov; 17(1):90. PubMed ID: 33228676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Socioeconomic factors and substances involved in poisoning-related emergency department visits in British Columbia, Canada.
    Pawer S; Rajabali F; Zheng A; Pike I; Purssell R; Zargaran A; Babul S
    Health Promot Chronic Dis Prev Can; 2021; 41(7-8):211-221. PubMed ID: 34427419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Motivations for concurrent use of uppers and downers among people who access harm reduction services in British Columbia, Canada: findings from the 2019 Harm Reduction Client Survey.
    Steinberg A; Mehta A; Papamihali K; Lukac CD; Young S; Graham B; Lock K; Fleury M; Buxton JA
    BMJ Open; 2022 May; 12(5):e060447. PubMed ID: 35501101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
    Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
    BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
    Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L
    PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2023 May; 80(5):508-514. PubMed ID: 36988913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.
    Kravitz-Wirtz N; Davis CS; Ponicki WR; Rivera-Aguirre A; Marshall BDL; Martins SS; Cerdá M
    JAMA Netw Open; 2020 Jan; 3(1):e1919066. PubMed ID: 31922561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlates of seeking emergency medical help in the event of an overdose in British Columbia, Canada: Findings from the Take Home Naloxone program.
    Karamouzian M; Kuo M; Crabtree A; Buxton JA
    Int J Drug Policy; 2019 Sep; 71():157-163. PubMed ID: 30691944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feeling safer: effectiveness, feasibility, and acceptability of continuous pulse oximetry for people who smoke opioids at overdose prevention services in British Columbia, Canada.
    Moe J; Chavez T; Marr C; Cameron F; Feldman-Kiss D; Wang YE; Xavier JC; Mamdani Z; Purssell RA; Salmon A; Buxton JA
    Harm Reduct J; 2024 Feb; 21(1):45. PubMed ID: 38378610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.
    Wallace B; Pagan F; Pauly BB
    Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.